The Scientist Creative Services Team in collaboration with Tecan | May 28, 2021 | 1 min read
Cammie Lesser will discuss how she turns a probiotic into a drug-delivering machine, while Andrew Y. Koh will describe the connection between the gut microbiota and cancer immunotherapy efficacy.
Jennifer T. Smilowitz and Diana Hazard Taft | Jun 1, 2020 | 10+ min read
The gut microbiome is more malleable in the first two years after birth, allowing probiotics to make their mark. Can we exploit this to improve infants’ health?
Jennifer T. Smilowitz and Diana Hazard Taft | Jun 1, 2020 | 3 min read
The microbial makeup of a newborn baby’s intestines has changed dramatically over the past 100 years, and we are now beginning to understand how and why this matters.
Experiments in mice and people find that probiotic supplements don’t consistently change the composition of the gut microbiome, and may have adverse effects after antibiotics.
Four years after taking a probiotic and peanut protein for 18 months, two-thirds of children in a small clinical trial can eat peanuts with no health issues.
